SCHEMBL7401075

SCHEMBL7401075

COC[C@@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4290559 1.00
SCHEMBL87687 1.00
Water SCHEMBL15624794 0.97
Hydrochloric Acid SCHEMBL5902943 0.97
Hydrochloric Acid SCHEMBL5903249 0.97
Hydrochloric Acid SCHEMBL1345156 0.94
SCHEMBL13024117 0.89 USP2 (0.52)
Bicarbonate SCHEMBL29012504 0.89 USP2 (0.42)
Propene SCHEMBL23277080 0.87 USP2 (0.41)
Ether SCHEMBL20873064 0.87 USP2 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS SERVIER LAB (FR) 2026-01-01 US disclosed
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 EP disclosed
CN-119816491-A New spirocyclohexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors 法国施维雅药厂 2025-04-11 CN disclosed
US-20250115620-A1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES, INC. 2025-04-10 US disclosed
EP-4438123-A2 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF Gilead Sciences, Inc. (US) 2024-10-02 EP disclosed
US-12054496-B2 Bridged tricyclic carbamoylpyridone compounds and uses thereof GILEAD SCIENCES, INC. (US) 2024-08-06 US disclosed
EP-4310087-B1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES INC (US) 2024-07-03 EP disclosed
US-12024528-B2 Bridged tricyclic carbamoylpyridone compounds and uses thereof GILEAD SCIENCES, INC. (US) 2024-07-02 US disclosed
EP-4388349-A1 CONTACT LENS CooperVision International Limited (GB) 2024-06-26 EP disclosed
EP-4305034-B1 BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF GILEAD SCIENCES INC (US) 2024-06-12 EP disclosed
EP-0891358-A1 OXAZOLIDIN-2-ONE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF SYNTHELABO (FR) 1999-01-20 EP disclosed
US-5843975-A Oxazolidinone derivatives, their preparation and therapeutical use SYNTHELABO (FR) 1998-12-01 US disclosed
EP-0859776-A1 COMPOUNDS DERIVED FROM OXAZOLIDIN-2-ONE AND PREPARATION AND THERAPEUTICAL USE THEREOF SYNTHELABO (FR) 1998-08-26 EP disclosed
WO-1997017347-A1 COMPOUNDS DERIVED FROM OXAZOLIDIN-2-ONE AND PREPARATION AND THERAPEUTICAL USE THEREOF SYNTHELABO (FR) 1997-05-15 WO disclosed
WO-1997013768-A1 OXAZOLIDIN-2-ONE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF SYNTHELABO (FR) 1997-04-17 WO disclosed
WO-1996038444-A1 OXAZOLIDINONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTICAL USE SYNTHELABO (FR) 1996-12-05 WO disclosed
CN-1031619-C Oxazolidinone derivatives for the production of medicaments EISAI CO LTD (JP) 1996-04-24 CN disclosed
CN-1113240-A Oxazolidone derivative EISAI CO LTD (JP) 1995-12-13 CN disclosed
CN-1071665-A Oxazolidinone Derivatives EISAI CO LTD (JP) 1993-05-05 CN disclosed
EP-0050460-A2 Tridecyloxy- or tetradecyloxy-propane derivatives, and their use Takeda Chemical Industries, Ltd. (JP) 1982-04-28 EP disclosed